Effect of a Long-Term Intensive Lifestyle Intervention on Cognitive Function: Action for Health in Diabetes Study. 2017

Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
Department of Psychiatry and Behavioral Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.

OBJECTIVE To assess whether randomization to 10 years of lifestyle intervention to induce and maintain weight loss improves cognitive function. METHODS Randomized controlled clinical trial. METHODS Data obtained as part of the Action for Health in Diabetes (Look AHEAD) trial (NCT00017953) and Look AHEAD Continuation study (U01 DK057136-15). METHODS Overweight and obese individuals with type 2 diabetes mellitus aged 45 to 76 (N = 3,751). METHODS Intensive lifestyle intervention (ILI) for weight loss through reduced caloric intake and increased physical activity compared with a control condition of diabetes support and education (DSE). METHODS Certified examiners who were masked to intervention assignment administered a standard battery of cognitive function tests (Modified Mini-Mental State Examination, Rey Auditory Verbal Learning Test, Digit Symbol Coding, Trail-Making Test, Modified Stroop Color-Word Test) to participants 10 to 13 years after enrollment. RESULTS Assignment to lifestyle intervention was not associated with significantly different overall (P = .10) or domain-specific (all P > .10) cognitive function than assignment to diabetes support and education. Results were fairly consistent across prespecified groups, but there was some evidence of trends for differential intervention effects showing modest harm in ILI in participants with greater body mass index and in individuals with a history of cardiovascular disease. Cognitive function was not associated with changes in weight or fitness (all P > .05). CONCLUSIONS A long-term behavioral weight loss intervention for overweight and obese adults with diabetes mellitus was not associated with cognitive benefit. Trial Registration clinicaltrials.gov Identifier: NCT00017953.

UI MeSH Term Description Entries
D008019 Life Style Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed) Lifestyle Factors,Life Style Induced Illness,Lifestyle,Factor, Lifestyle,Life Styles,Lifestyle Factor,Lifestyles
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females

Related Publications

Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
October 2023, The journals of gerontology. Series A, Biological sciences and medical sciences,
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
January 2018, Alzheimer's & dementia (Amsterdam, Netherlands),
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
January 2018, Journal of the American Geriatrics Society,
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
August 2021, Obesity (Silver Spring, Md.),
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
July 2019, Obesity (Silver Spring, Md.),
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
May 2021, Journal of diabetes and its complications,
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
October 2022, The journals of gerontology. Series A, Biological sciences and medical sciences,
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
January 2015, Obesity (Silver Spring, Md.),
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
August 2020, Neurobiology of aging,
Stephen R Rapp, and Jose A Luchsinger, and Laura D Baker, and George L Blackburn, and Helen P Hazuda, and Kathryn E Demos-McDermott, and Robert W Jeffery, and Jeffrey N Keller, and Jeanne M McCaffery, and Nicholas M Pajewski, and Mary Evans, and Thomas A Wadden, and Steven E Arnold, and Mark A Espeland, and
January 2017, BMJ open diabetes research & care,
Copied contents to your clipboard!